Acomhal Research

Roanoke, United States

Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells.

$305K raised

Jan 2022

Grant

Biotechnology Health Care Life Science

Top Investors

Virginia Innovation Partnership Corporation Virginia Tech Carilion (VTC) Innovation Fund CommonWealth Angels

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acomhal Research

How much funding has Acomhal Research raised?

Acomhal Research has raised $305K in total funding. The most recent round was Grant. The last funding was announced in January 2022.

Who are Acomhal Research's investors?

Acomhal Research's investors include Virginia Innovation Partnership Corporation, Virginia Tech Carilion (VTC) Innovation Fund, CommonWealth Angels.

Where is Acomhal Research headquartered?

Acomhal Research is headquartered in Roanoke, United States.

What does Acomhal Research do?

Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells.

What stage is Acomhal Research at?

Acomhal Research is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 4, 2022.

MLA

"Acomhal Research — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/acomhal-research. Accessed July 2, 2026.

APA

VCBacked. (2022). Acomhal Research — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/acomhal-research

Wikipedia (cite web)

{{cite web |title=Acomhal Research — Funding & Investors |url=https://www.vcbacked.co/company/acomhal-research |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 4, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K